Sophiris Bio Inc fka SPHS

[Eli's Gone]

SAN DIEGO and VANCOUVER, British Columbia, Jan. 30, 2017 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the BetterInvesting™ Virtual Investor Conference. The presentation will take place on Thursday February 2, 2017 at 1:00 p.m. Eastern Time.

The presentation will be webcast live at http://tinyurl.com/0202prepr and can also be accessed through the Investor Relations page at www.sophiris.com. A replay of the presentation will be available on the Company's website for 90 days.

http://investor.sophirisbio.com/events.cfm

http://www.prnewswire.com/news-releases/sophiris-bio-to-webcast-live-presentation-at-betterinvestings-virtual-investor-conference-300398918.html